Generation of Induced Pluripotent Stem Cell Line iTAF15Xsk4 from Fibroblasts of a Patient with Microdeletion at Xq24

被引：1
|
作者：
Pristyazhnyuk, I. E. [1 ]
Meshcheryakov, N. I. [1 ,2 ]
Nikitina, T. V. [3 ]
Kashevarova, A. A. [3 ]
Fedotov, D. A. [3 ]
Tolmacheva, E. N. [3 ]
Minaycheva, L. I. [3 ]
Nazarenko, L. P. [3 ]
Lebedev, I. N. [3 ]
Menzorov, A. G. [1 ,2 ]
机构：
[1] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia
[2] Novosibirsk State Univ, Novosibirsk 630090, Russia
[3] Russian Acad Sci, Tomsk Natl Res Med Ctr, Res Inst Med Genet, Tomsk 634050, Russia
来源：
RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY | 2023年 / 54卷 / 06期
基金：
俄罗斯科学基金会;
关键词：
iPSCs; Xq24; microdeletion; UBE2A deficiency syndrome; recurrent pregnancy loss; skewed X-chromosome inactivation; UBE2A DEFICIENCY SYNDROME; INDUCTION; CULTURES; BLOOD;
D O I：
10.1134/S1062360423060073
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Differentiation of induced pluripotent stem cells (iPSCs) from patients and healthy donors allows in vitro study of genetic disorders. The authors have previously reported a clinical case of recurrent pregnancy loss in a patient with skewed X-chromosome inactivation in peripheral blood lymphocytes, endometrium, and buccal epithelium. A 239 kb microdeletion at Xq24 that affected eight genes, including UBE2A, has been found. In this work, an iPSC line iTAF15Xsk4 was produced from the patient's skin fibroblasts using nonintegrating episomal vectors. The iPSC line had a normal karyotype, expressed pluripotency markers, and expressed markers of all three germ layers upon differentiation in embryoid bodies. This cell line could be used for the UBE2A deficiency syndrome study.
引用
收藏
页码：358 / 364
页数：7
相关论文
共 50 条
  • [31] Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2
    Fatima, Azra
    Ivanyuk, Dina
    Herms, Stefan
    Heilmann-Heimbach, Stefanie
    O'Shea, Orla
    Chapman, Charlotte
    Izsvak, Zsuszanna
    Farr, Martin
    Hescheler, Juegen
    Saric, Tomo
    STEM CELL RESEARCH, 2016, 16 (02) : 304 - 307
  • [32] Generation of an induced pluripotent stem cell line from a compound heterozygous patient in TK2 gene
    Hernandez-Ainsa, Carmen
    Nascimento, Andres
    Jou, Cristina
    Artuch, Rafael
    Montoya, Julio
    Ruiz-Pesini, Eduardo
    Emperador, Sonia
    STEM CELL RESEARCH, 2022, 59
  • [33] Generation of the induced pluripotent stem cell line ESi108-A from a familial atrial fibrillation patient
    Martinez-Moreno, Rebecca
    Perez-Serra, Alexandra
    Selga, Elisabet
    Carreras, David
    Aran, Begona
    Kuebler, Bernd
    Scornik, Fabiana S.
    Perez, Guillermo J.
    Brugada, Ramon
    STEM CELL RESEARCH, 2023, 73
  • [34] Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy
    Claassen, Johann N.
    Zhang, Dan
    Chen, Shang-Chih
    Moon, Sang Yoon
    Lamey, Tina
    Thompson, Jennifer A.
    McLaren, Terri
    De Roach, John N.
    McLenachan, Samuel
    Chen, Fred K.
    STEM CELL RESEARCH, 2019, 34
  • [35] Establishment of human induced pluripotent stem cell line from dermal fibroblasts of a healthy individual
    Huo, Yinghao
    Wang, Jin
    He, Jingjing
    Kong, Desheng
    Ma, Jun
    STEM CELL RESEARCH, 2020, 44
  • [36] Generation of an Induced Pluripotent Stem Cell Line TNRMCi001-A by Reprogramming Fibroblasts from a Homozygous F508del Cystic Fibrosis Patient
    Zhigalina, D. I.
    Kireeva, T. N.
    Nikitina, T. V.
    Odinokova, O. N.
    Kolesnikov, N. A.
    Malakhova, A. A.
    Savchenko, R. R.
    Zhalsanova, I. Zh.
    Valiahmetov, N. R.
    Postrigan, A. E.
    Vovk, S. L.
    Torkhova, N. B.
    Frolova, A. A.
    Stepanov, V. A.
    Skryabin, N. A.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (SUPPL 1) : S68 - S74
  • [37] Characterization of an induced pluripotent stem cell line (IMBPASi001-A) derived from fibroblasts of a patient affected by Wolfram Syndrome
    Grzela, Dawid P.
    Marciniak, Beata
    Pulaski, Lukasz
    STEM CELL RESEARCH, 2020, 46
  • [38] Generation of a human induced pluripotent stem cell line (FSMi001-A) from fibroblasts of a patient carrying heterozygous mutation in the REEP1 gene
    Baggiani, Matteo
    Santorelli, Filippo Maria
    Mero, Serena
    Privitera, Flavia
    Damiani, Devid
    Tessa, Alessandra
    STEM CELL RESEARCH, 2024, 79
  • [39] Generation of an induced pluripotent stem cell line, ZIPi021-A, from fibroblasts of a Prader-Willi syndrome patient with maternal uniparental disomy (mUPD)
    Heseding, Hannah
    Jahn, Kirsten
    Braendl, Bjoern
    Haase, Alexandra
    Shum, Ian O.
    Kohrn, Tim
    Bleich, Stefan
    Frieling, Helge
    Martin, Ulrich
    Mueller, Franz-Josef
    Wunderlich, Stephanie
    Deest, Maximilian
    STEM CELL RESEARCH, 2023, 71
  • [40] Generation of an Induced Pluripotent Stem Cell Line TNRMCi001-A by Reprogramming Fibroblasts from a Homozygous F508del Cystic Fibrosis Patient
    D. I. Zhigalina
    T. N. Kireeva
    T. V. Nikitina
    O. N. Odinokova
    N. A. Kolesnikov
    A. A. Malakhova
    R. R. Savchenko
    I. Zh. Zhalsanova
    N. R. Valiahmetov
    A. E. Postrigan
    S. L. Vovk
    N. B. Torkhova
    A. A. Frolova
    V. A. Stepanov
    N. A. Skryabin
    Russian Journal of Developmental Biology, 2023, 54 : S68 - S74
12345